Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Cannara Biotech
(OTCQB:LOVFF)
Intraday
$0.537
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.537
0
[0.00%]
At close: May 9
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Cannara Biotech Stock (OTC:LOVFF)
Cannara Biotech Stock (OTC: LOVFF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, May 01, 2024
Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss
Jelena Martinovic
-
May 1, 2024, 3:45PM
Wednesday, February 07, 2024
Cannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Also Marks Company's First Export Sale
Meg Flippin
-
Sponsored
Tuesday, December 12, 2023
Cannara Biotech Market Share Gains Result In Record-Setting Fourth Quarter
Meg Flippin
-
Sponsored
Thursday, December 07, 2023
This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices
Johnny Rice
-
Dec 7, 2023, 1:47PM
Monday, August 21, 2023
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
Benzinga Insights
-
Aug 21, 2023, 5:30PM
Thursday, August 10, 2023
Cannabis Stock Movers For August 10, 2023
Benzinga Insights
-
Aug 10, 2023, 5:30PM
Friday, August 04, 2023
Cannabis Stock Gainers And Losers From August 4, 2023
Benzinga Insights
-
Aug 4, 2023, 5:30PM
Tuesday, August 01, 2023
Marijuana Stock Movers For August 1, 2023
Benzinga Insights
-
Aug 1, 2023, 5:30PM
Thursday, July 27, 2023
Cannabis Stock Movers For July 27, 2023
Benzinga Insights
-
Jul 27, 2023, 5:30PM
Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA?
Vuk Zdinjak
-
Jul 27, 2023, 9:09AM
Tuesday, July 25, 2023
Cannabis Stock Gainers And Losers From July 25, 2023
Benzinga Insights
-
Jul 25, 2023, 5:30PM
Thursday, May 04, 2023
Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking
Vuk Zdinjak
-
May 4, 2023, 10:15AM
Monday, April 24, 2023
Cannara Biotech Q2 FY23 Revenue Grows 76% YoY To $9.6M, Here Are The Details
Vuk Zdinjak
-
Apr 24, 2023, 9:06AM
Friday, February 10, 2023
Olymbec Investments Increases Its Ownership In Cannara Biotech
Vuk Zdinjak
-
Feb 10, 2023, 9:12AM
Monday, January 23, 2023
Cannara Biotech Q1 Revenue Grows 57% YoY To $7.7M, What About Adjusted EBITDA?
Vuk Zdinjak
-
Jan 23, 2023, 8:59AM
Monday, November 28, 2022
Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M
Vuk Zdinjak
-
Nov 28, 2022, 10:16AM
Tuesday, September 20, 2022
Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products
Vuk Zdinjak
-
Sep 20, 2022, 10:02AM
Wednesday, August 03, 2022
Cannara Biotech Signs An Exclusive Brand Partnership With Exotic Genetix In Canada
Vuk Zdinjak
-
Aug 3, 2022, 10:36AM
Wednesday, July 27, 2022
Cannara Biotech Revenue Grows 41% YoY, Here Are The Details
Vuk Zdinjak
-
Jul 27, 2022, 9:06AM
Thursday, June 02, 2022
Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking
Vuk Zdinjak
-
Jun 2, 2022, 9:00AM
Wednesday, April 27, 2022
Cannara Biotech Revenues Grew 229% To $7.4M In Q2 2022 YoY
Vuk Zdinjak
-
Apr 27, 2022, 1:44PM
Tuesday, February 01, 2022
New Kids On The Block: Is A Second Wave Of Canadian Cannabis Here?
Johnny Rice
-
Sponsored
Saturday, January 22, 2022
What Was In Cannara Biotech's Q1 Earnings Report?
Javier Hasse
-
Jan 22, 2022, 12:54PM
Friday, December 10, 2021
The Week In Cannabis: Isiah Thomas, Tilray, The DEA, Ohio, Mexico And More
Javier Hasse
-
Dec 10, 2021, 3:04PM
Thursday, December 09, 2021
Cannara Biotech Shares Surge On 983% QoQ Revenue Growth, Positive Adjusted EBITDA
Nina Zdinjak
-
Dec 9, 2021, 9:16AM
Monday, August 02, 2021
Tilray Best Performer Among Canadian Cannabis LPs, Stocks Plunge Nearly 10% In July
Jelena Martinovic
-
Aug 2, 2021, 1:34PM
Thursday, July 29, 2021
Cannara Biotech Cannabis Co. Slightly Beats Estimates, Posts $7.2M In Q3 2021 Revenue
Jelena Martinovic
-
Jul 29, 2021, 2:22PM
Friday, July 02, 2021
The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More
Javier Hasse
-
Jul 2, 2021, 5:09PM
Monday, June 28, 2021
Cannara Biotech Cannabis Co. Expects To Post $7.1M In Q3 Revenue After Successful Market Launch In Quebec
Jelena Martinovic
-
Jun 28, 2021, 2:03PM
Friday, April 17, 2020
Cannabis Earnings Roundup: Avicanna, Cannara Biotech, Halo Labs
Nina Zdinjak
-
Apr 17, 2020, 10:49AM
Friday, February 21, 2020
FSD Pharma Sells Cannara Biotech Stake, Netting More Than $7.7M
Javier Hasse
-
Feb 21, 2020, 12:20PM
Friday, August 16, 2019
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
-
Aug 16, 2019, 10:35AM
Thursday, August 15, 2019
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
-
Aug 15, 2019, 11:17AM
